Cargando…

Overexpression of GLT1D1 induces immunosuppression through glycosylation of PD‐L1 and predicts poor prognosis in B‐cell lymphoma

B‐cell non‐Hodgkin's lymphoma (NHL) is a class of heterogeneous diseases with variable clinical outcomes. Immunosuppression is particularly common in the subtypes of lymphoma with poor prognosis, but the underlying mechanism remains unclear. Using a RT‐PCR array analysis, we have identified tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaoxia, Zhang, Yanyu, Han, Yi, Lu, Wenhua, Yang, Jing, Tian, Jingyu, Sun, Peng, Yu, Tiantian, Hu, Yumin, Zhang, Hui, Huang, Peng, Liu, Panpan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191186/ https://www.ncbi.nlm.nih.gov/pubmed/32157792 http://dx.doi.org/10.1002/1878-0261.12664

Ejemplares similares

GLT-1 Knockdown Inhibits Ceftriaxone-Mediated Improvements on Cognitive Deficits, and GLT-1 and xCT Expression and Activity in APP/PS1 AD Mice
por: Gao, JunXia, et al.
Publicado: (2020)

The Effect of GLT-1 Upregulation on Extracellular Glutamate Dynamics
por: Wilkie, Crystal M., et al.
Publicado: (2021)

Glutamate Transporters GltS, GltP and GltI Are Involved in Escherichia coli Tolerance In Vitro and Pathogenicity in Mouse Urinary Tract Infections
por: Niu, Hongxia, et al.
Publicado: (2023)

Overexpression of CHAF1A is associated with poor prognosis, tumor immunosuppressive microenvironment and treatment resistance
por: Sun, Xia, et al.
Publicado: (2023)

Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer
por: Xu, Huimei, et al.
Publicado: (2023)

Correction: Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer
por: Xu, Huimei, et al.
Publicado: (2023)

Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response
por: Chen, Gang, et al.
Publicado: (2018)

Targeting glycosylation of PD-1 to enhance CAR-T cell cytotoxicity
por: Shi, Xiaojuan, et al.
Publicado: (2019)

Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jung, Hae Il, et al.
Publicado: (2017)

Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
por: Pu, Yunzhou, et al.
Publicado: (2022)

Upregulation of GLT-1 via PI3K/Akt Pathway Contributes to Neuroprotection Induced by Dexmedetomidine
por: Peng, Mengyuan, et al.
Publicado: (2019)

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
por: Creaney, J, et al.
Publicado: (2008)

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

Activation of Glutamate Transporter-1 (GLT-1) Confers Sex-Dependent Neuroprotection in Brain Ischemia
por: Tejeda-Bayron, Flavia A., et al.
Publicado: (2021)

Immunosuppression in Gliomas via PD-1/PD-L1 Axis and Adenosine Pathway
por: Scheffel, Thamiris Becker, et al.
Publicado: (2021)

Identification of a monoclonal antibody that targets PD-1 in a manner requiring PD-1 Asn58 glycosylation
por: Wang, Mingzhu, et al.
Publicado: (2019)

Glutamate Transporter GLT1 Expression in Alzheimer Disease and Dementia With Lewy Bodies
por: Garcia-Esparcia, Paula, et al.
Publicado: (2018)

Neuronal Loss of the Glutamate Transporter GLT-1 Promotes Excitotoxic Injury in the Hippocampus
por: Rimmele, Theresa S., et al.
Publicado: (2021)

Overexpression of PD‐L1 causes germ cells to slough from mouse seminiferous tubules via the PD‐L1/PD‐L1 interaction
por: Fang, Lian, et al.
Publicado: (2022)

Overexpression of NRP1 is Associated with Poor Prognosis via Accelerating Immunosuppression in Head and Neck Squamous Cell Carcinoma
por: Yang, Xueming, et al.
Publicado: (2023)

Prognostic Significance of Programmed Cell Death 1 (PD-1) or PD-1 Ligand 1 (PD-L1) Expression in Epithelial-Originated Cancer: A Meta-Analysis
por: Zhang, Yaxiong, et al.
Publicado: (2015)

PD1/PD-L1 dependent immunosuppression by huiPS-derived cell population
por: Pini, Jonathan, et al.
Publicado: (2011)

Astrocytic Glutamate Transporter 1 (GLT1) Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice
por: Jia, Yun-Fang, et al.
Publicado: (2020)

Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer
por: Jiang, Senwei, et al.
Publicado: (2022)

Self-actuated biomimetic nanocomposites for photothermal therapy and PD-L1 immunosuppression
por: Li, Wenxin, et al.
Publicado: (2023)

GLT-1 Promoter Activity in Astrocytes and Neurons of Mouse Hippocampus and Somatic Sensory Cortex
por: de Vivo, Luisa, et al.
Publicado: (2010)

Characterization of the Visceral Antinociceptive Effect of Glial Glutamate Transporter GLT-1 Upregulation by Ceftriaxone
por: Roman, K., et al.
Publicado: (2012)

Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy
por: Sha, Longze, et al.
Publicado: (2017)

The Expression of GLAST and GLT1 in a Transient Cerebral Ischemia Mongolian Gerbil Model
por: Shen, Yanling, et al.
Publicado: (2020)

The role of hippocampal glial glutamate transporter (GLT‐1) in morphine‐induced behavioral responses
por: Saeedi, Negin, et al.
Publicado: (2021)

PD-L1 induction via the MEK-JNK-AP1 axis by a neddylation inhibitor promotes cancer-associated immunosuppression
por: Zhang, Shizhen, et al.
Publicado: (2022)

PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease
por: Perrin, Florian, et al.
Publicado: (2023)

Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation
por: Shi, Chengyu, et al.
Publicado: (2022)

Association Between Tumor Mutation Burden (TMB) and Outcomes of Cancer Patients Treated With PD-1/PD-L1 Inhibitions: A Meta-Analysis
por: Zhu, Jiaxin, et al.
Publicado: (2019)

MR1 overexpression correlates with poor clinical prognosis in glioma patients
por: Kubica, Phillip, et al.
Publicado: (2021)

TM4 of the glutamate transporter GLT-1 experiences substrate-induced motion during the transport cycle
por: Rong, Xiuliang, et al.
Publicado: (2016)

Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinoma
por: Ma, Li-Jie, et al.
Publicado: (2018)

Vibration Induces BAFF Overexpression and Aberrant O-Glycosylation of IgA1 in Cultured Human Tonsillar Mononuclear Cells in IgA Nephropathy
por: Ye, Muyao, et al.
Publicado: (2016)

Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment
por: Huang, Yanyu, et al.
Publicado: (2021)

Proximity of Transmembrane Segments 5 and 8 of the Glutamate Transporter GLT-1 Inferred from Paired Cysteine Mutagenesis
por: Zhang, Xiuping, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b8sua3627q73e13hpckodh2qf0